Yan Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Squamous Cell Carcinoma

Smoking Cessation

Top Venues

The American journal of Chinese medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Xin Li, Xue He, Bing Lin, Li Li, Qifeng Deng, Chengzhi Wang, Jing Zhang, Ying Chen, Jingyi Zhao, Xinrui Li, Yan Li, Qing Xi, Rongxin Zhang
Quercetin Limits Tumor Immune Escape through PDK1/CD47 Axis in Melanoma. The American journal of Chinese medicine 52 (2) (2024)
Xin Li, Xue He, Bing Lin, Li Li, Qifeng Deng, Chengzhi Wang, Jing Zhang, Ying Chen, Jingyi Zhao, Xinrui Li, Yan Li, Qing Xi, Rongxin Zhang
Quercetin Limits Tumor Immune Escape through PDK1/CD47 Axis in Melanoma. The American journal of Chinese medicine 52 (2) (2024)
Xin Li, Xue He, Bing Lin, Li Li, Qifeng Deng, Chengzhi Wang, Jing Zhang, Ying Chen, Jingyi Zhao, Xinrui Li, Yan Li, Qing Xi, Rongxin Zhang
Quercetin Limits Tumor Immune Escape through PDK1/CD47 Axis in Melanoma. The American journal of Chinese medicine (2024)
Mengyi Zhu, Daoyang Chen, Chuangdong Ruan, Penghui Yang, Jinrong Zhu, Rongxin Zhang, Yan Li
CircRNAs: A Promising Star for Treatment and Prognosis in Oral Squamous Cell Carcinoma. International journal of molecular sciences 24 (18) (2023)
Huijiao Lu, Jia-Hua Liang, Xue He, Huabin Ye, Chuangdong Ruan, Hongwei Shao, Rongxin Zhang, Yan Li
A Novel Oncogenic Role of FDX1 in Human Melanoma Related to PD-L1 Immune Checkpoint. International journal of molecular sciences 24 (11) (2023)
Huijiao Lu, Mengyi Zhu, Lin Qu, Hongwei Shao, Rongxin Zhang, Yan Li
Oncogenic Role of HMGB1 as An Alarming in Robust Prediction of Immunotherapy Response in Colorectal Cancer. Cancers 14 (19) (2022)